✦ LIBER ✦

Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia

✍ Scribed by Furtner, M; Straub, R H; Krüger, S; Schwarz, H

Book ID: 110056197
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 83 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403675

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Admission levels of soluble CD137 are in

Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complications

✍ Zhe Shao; Andreas Schäffler; Okka Hamer; Judith Dickopf; Andrea Goetz; Karin Lan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 494 KB

CD38 expression levels in chronic lympho

CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation

✍ Pittner, B T; Shanafelt, T D; Kay, N E; Jelinek, D F 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 283 KB

A study of allergy in patients with mali

A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia

✍ David P. McCormick; Arthur J. Ammann; Kimishige Ishizaka; Daniel G. Miller; Rich 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Elevated serum levels of soluble CD44 ca

Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression

✍ Stefano Molica; Gaetano Vitelli; Domenico Levato; Diana Giannarelli; Giuseppe Ma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Prognostic value of plasma interleukin-6

Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia

✍ Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Hagop Kantarjian; Mich 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Background: Interleukin 6 (il-6) is a b-cell growth and differentiation factor, which may promote the growth of b-cell neoplasms. in chronic lymphocytic leukemia (cll) patients, il-6 plasma levels increased in a stage-dependent manner, suggesting that il-6 may be a useful prognostic marker. the

A phase I/II study of rituximab and etan

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

✍ Lin, T S; Lucas, M S; Heerema, N; Moran, M E; Cheney, C; Woyach, J A; Lucas, D M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB